| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $60.9M | +117.6% |
| SG&A Expense | $22.1M | +170.4% |
| Operating Income | -$83.1M | -129.6% |
| Pre-tax Income | -$78.3M | -125.2% |
| Income Tax | $0 | -100.0% |
| Net Income | -$78.3M | -125.0% |
| EPS (Basic) | -$3.78 | +83.6% |
| EPS (Diluted) | -$3.78 | +83.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.8M | -19.0% |
| Short-term Investments | $248.5M | +221.4% |
| Current Assets | $309.8M | +105.3% |
| Total Assets | $314.9M | +102.6% |
| Current Liabilities | $8.8M | -0.4% |
| Total Liabilities | $9.5M | -34.3% |
| Stockholders' Equity | $305.4M | +1291.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.8M | -138.5% |
| Capital Expenditures | $2.4M | +47.0% |
| Investing Cash Flow | -$170.1M | -115.8% |
| Financing Cash Flow | $221.6M | +52.7% |
| Free Cash Flow | -$67.2M | -133.3% |